Meningococcal Vaccine Market exhibiting CAGR of 7.9% from 2023 to 2032, owing to increasing prevalence of meningitis | insightSLICE
The Meningococcal Vaccine market had a value of US$ 3.9 billion in 2021 and is projected to increase at a CAGR of 7.9% through 2032.
Even though the meningitis spread has decreased over the last 20 years, there were still 5 million new cases and nearly 290,000 deaths worldwide in 2017. Meningitis outbreaks were reported in roughly 157 African countries’ districts between 2010 and 2017, as per the estimates by the WHO. The population in some of these nations is in significant danger because the recommended meningitis immunization program is still not widely available.
Access the sample report: https://www.insightslice.com/request-sample/561
The key players of the Global Meningococcal Vaccine Market are:
Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline, plc, CSL Limited, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Emergent BioSolutions, Inc., Sanofi Pasteur SA, Astellas Pharma Inc., Serum Institute of India Pvt. Ltd., Johnson & Johnson, Protein Sciences Corporation, MedImmune, LLC, and Panacea Biotec are a few of the leading companies in the Meningococcal Vaccine Market.
These companies are concentrating on expanding their distribution networks in nations with underdeveloped healthcare facilities. Companies are targetting countries as they possess an untapped potential for their expansion during the anticipated period.
Companies are also developing vaccinations that offer a higher rate of meningitis prevention to achieve a competitive edge. For example, the FDA authorized MenQuadfi, a novel meningococcal conjugate vaccine made by Sanofi S.A., in April 2020.
Increasing meningococcal infections are a cause of concern:
Neisseria meningitides are the bacterium that causes meningococcal illness. Meningococcus is yet another name for this bacterium. This produces a thin layer of lining around the spinal cord and brain and results in a dangerous infection.
This infection can result in serious illness and is frequently fatal. If addressed late, the fatality rate could reach 50%. To prevent problems and preserve lives, early identification and treatment are essential. Through the transfer of respiratory and throat fluids, this bacterium spreads across individuals.
Read more about the report inclusions: https://www.insightslice.com/meningococcal-vaccine-market
Antibiotics can be used to treat this, but a prompt diagnosis is required to have significant recovery. Meningococcal immunization can stop this disease from occurring and help prevent further complications.
Meningococcal conjugate and serogroup B meningococcal vaccines are currently the two forms of meningococcal vaccinations that are readily available.
Vaccination is a sure-shot method to tackle meningitis disease:
Meningococcal meningitis cases are seen all over the world, however, the region of Sub-Saharan Africa has a greater incidence of this illness. In this area, almost 30,000 instances are reported each year.
To combat meningitis, various global health agencies, commercial businesses, academic research institutions/universities, and public health authorities are collaborating to introduce solutions. The World Health Organization (WHO) has also developed a plan to eradicate meningitis by the year 2030.
It has outlined a strategy for addressing bacterial meningitis sources. This road map outlines the important steps in disease monitoring, preventive and outbreak control, disease treatment and diagnosis, and assistance for those who are afflicted. Such activities will aid in the Meningococcal Vaccine market’s expansion during the forecast period.
Excellent coverage of all factors affecting the meningococcal vaccine market are covered:
Our report will provide precise market share, developments, analysis, and estimates for the meningococcal vaccine market. The basis year for our report’s projections is 2021, the historical period is up to 2020, and the forecast timeframe is 2022–2032.
The analysis offers insights into the competitive environment as well as a detailed company background and trade forecast for the main companies in the global meningococcal vaccine market.
Additionally, information on all prominent firms operating in the meningococcal vaccine marketplace will be included in the study, including key developments, local and global income, market indicators, R&D efforts, and critical management decisions.
The study highlights the operating business units collaborating on the creation and development of the meningococcal vaccination.
Along with their major business strategies, brand catalogs, major goals, and crucial market analysis along with market shares of well-known companies competing in the global meningococcal vaccination market will be assessed.
We’ll also look at the strategic procurement and marketing program partners and their involvement in the meningococcal vaccine market.
The business press release portion of the website will focus on the latest recent company developments, including corporate strategy, collaborations, corporate restructuring, new flagship product lines, and global coverage of the meningococcal vaccine market.
The product portfolio section of the website will focus on all currently offered and upcoming products.
Regional performance of Meningococcal Vaccine Market
The meningococcal vaccination market is currently dominated by the North American region. This is related to the region’s increased vaccination rates because meningococcal vaccination for children enrolled in high school and college is required in several states.
Government initiatives of this form are supporting the development of the meningococcal vaccine market in North American countries.
Proceed to purchase: https://www.insightslice.com/buy-now/561
Global Meningococcal Vaccine Market Key Segments:
By Type
- Polysaccharide
- Bivalent
- Trivalent
- Tetravalent
- Conjugate
- Others
By Age group
- Infant
- Adults
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
Related reports:
Global Surgical Face Mask Market: https://www.insightslice.com/surgical-face-mask-market
Global Fetal Bovine Serum Market: https://www.insightslice.com/fetal-bovine-serum-market
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
